Article
Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma
21 Sept 2023
Abstract excerpt
Canine hemangiosarcoma (HSA) is an aggressive cancer of endothelial cells with short survival times. Understanding the genomic landscape of HSA may aid in developing therapeutic strategies for dogs and may also inform therapies for the rare and aggressive human cancer angiosarcoma. The objectives of this study were to build a framework for leveraging real-world genomic and clinical data that could provide the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
